2017-01-25,SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Dipexium Pharma - DPRX
2016-12-22,Dipexium And PLx Pharma Announce Merger Agreement
2016-10-25,Dipexium Announces Top-line Data From OneStep Phase 3 Trials With Locilex® In Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint Of Superiority Versus Vehicle Plus Standardized Wound Care
2016-10-20,Dipexium Provides Update On Availability Of Results From Pivotal Phase 3 Clinical Trials With Locilex®
2016-10-04,Dipexium Receives European Medicines Agency Designation As A Small And Medium Enterprise
2016-09-07,Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
2016-08-24,Dipexium Pharmaceuticals Announces Participation In September Investor Conferences
2016-07-28,Dipexium Pharmaceuticals To Hold Second Quarter 2016 Financial Results Conference Call On Thursday, August 4, 2016, At 8:30 A.m. ET
2016-06-20,Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented At ASM Microbe 2016 Conference
2016-05-16,Dipexium Announces Completion Of Enrollment Objective In OneStep-1 Pivotal Phase 3 Clinical Trial
2016-05-09,Dipexium Pharmaceuticals To Hold First Quarter 2016 Financial Results Conference Call On Thursday, May 12, 2016, At 8:30 A.m. ET
2016-03-28,Dipexium Pharmaceuticals Announces Issuance Of Locilex® Patent In Japan
2016-03-14,Dipexium Pharmaceuticals to Hold Year End 2015 Financial Results Conference Call on Wednesday, March 23, 2016, 8:30 a.m. ET
2016-03-02,Dipexium Pharmaceuticals Announces Presentation At Raymond James 37th Annual Institutional Investors Conference
2016-02-24,8 Stocks Under $10 Making Big Moves Higher
2016-02-04,Dipexium Pharmaceuticals Reaches 75% Enrollment Milestone In Pivotal Phase 3 Clinical Trials
2016-02-01,Dipexium Pharmaceuticals Announces Issuance Of Locilex® Patents In Australia And New Zealand
2016-01-29,Dipexium Pharmaceuticals Announces Presentation At 18th Annual BIO CEO & Investor Conference
2015-12-01,Dipexium Pharmaceuticals Announces Presentation At Oppenheimer 26th Annual Healthcare Conference
2015-11-09,Dipexium Pharmaceuticals To Hold Third Quarter 2015 Financial Results Conference Call On Monday, November 16, 2015, At 8:30 A.m. ET
2015-10-01,Dipexium Pharmaceuticals Reaches 50% Enrollment In Second Pivotal Phase 3 Clinical Trial
2015-09-21,Dipexium Pharmaceuticals Presents Locilex® Microbiology Data At ICAAC/ICC 2015 Conference
2015-08-31,Dipexium Pharmaceuticals Announces Participation In Four Investor Conferences In September
2015-08-20,Dipexium Pharmaceuticals Surpasses Treatment Of 50% Of Subjects In Pivotal Phase 3 Clinical Trial
2015-08-06,Dipexium Pharmaceuticals To Hold Second Quarter 2015 Financial Results Conference Call On Thursday, August 13, 2015, At 8:30 A.m. ET
2015-07-28,Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant To Other Topical Antibiotics
2015-06-30,Dipexium Announces Closing Of Public Offering Of Common Stock
2015-06-25,Dipexium Announces Pricing Of Public Offering Of Common Stock
2015-06-24,Dipexium Announces Proposed Public Offering Of Common Stock
2015-06-02,Dipexium Receives European Medicines Agency Scientific Advice On Clinical And Regulatory Pathway For Locilex® Marketing Approval In European Union
2015-05-21,Dipexium Announces Presentation At 7th International Symposium On The Diabetic Foot
2015-05-07,Dipexium Pharmaceuticals To Hold First Quarter 2015 Financial Results Conference Call On Thursday, May 14, 2015, At 8:30 A.m. ET
2015-03-18,Dipexium Pharmaceuticals To Hold Year End 2014 Financial Results Conference Call On Tuesday, March 24, 2015, 8:30 A.m. ET
2015-03-12,Dipexium Pharmaceuticals To Present At Jefferies 2015 Antibiotic Summit
2015-02-25,Dipexium Pharmaceuticals Passes 25% Enrollment In Locilex® Pivotal Phase 3 Clinical Trials
2015-02-17,Dipexium Pharmaceuticals Announces Successful Completion And Initial Results Of Phase 1 Skin Sensitization Trial Of Locilex®
2015-02-02,Dipexium Pharmaceuticals Announces Presentation At 17th Annual BIO CEO & Investor Conference
2014-11-17,Dipexium Pharmaceuticals Announces Presentation At Oppenheimer 25th Annual Healthcare Conference
2014-09-10,3 Under-$10 Stocks Triggering Breakout Trades
2014-09-08,Dipexium Pharmaceuticals Presents Updated Locilex® Microbiology Data At 54th ICAAC Conference
2014-09-02,Dipexium Pharmaceuticals Announces Presentation At Rodman & Renshaw 16th Annual Global Investment Conference
2014-07-21,Dipexium Pharmaceuticals Initiates Second Of Two Pivotal Phase 3 Clinical Trials Of Locilex® In Patients With Mild Infections Of Diabetic Foot Ulcers
2014-07-17,Dipexium Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial Of Locilex® In Patients With Mild Infections Of Diabetic Foot Ulcers
2014-07-17,Dipexium Pharmaceuticals Announces Successful Completion Of Phase 1 Skin Irritation Trial Of Locilex®
,
,
,
,
